- Home
- ATEN vs FDMT Comparison
ATEN vs FDMT Comparison
Compare ATEN & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATEN
- FDMT
- Stock Information
- Founded
- ATEN 2004
- FDMT 2013
- Country
- ATEN United States
- FDMT United States
- Employees
- ATEN N/A
- FDMT N/A
- Industry
- ATEN EDP Services
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- ATEN Technology
- FDMT Health Care
- Exchange
- ATEN Nasdaq
- FDMT Nasdaq
- Market Cap
- ATEN 1.0B
- FDMT 479.7M
- IPO Year
- ATEN 2014
- FDMT 2020
- Fundamental
- Price
- ATEN $14.74
- FDMT $8.45
- Analyst Decision
- ATEN Strong Buy
- FDMT Strong Buy
- Analyst Count
- ATEN 2
- FDMT 9
- Target Price
- ATEN $16.50
- FDMT $46.88
- AVG Volume (30 Days)
- ATEN 556.3K
- FDMT 1.0M
- Earning Date
- ATEN 11-07-2024
- FDMT 11-07-2024
- Dividend Yield
- ATEN 1.63%
- FDMT N/A
- EPS Growth
- ATEN N/A
- FDMT N/A
- EPS
- ATEN 0.57
- FDMT N/A
- Revenue
- ATEN $248,963,000.00
- FDMT $20,218,000.00
- Revenue This Year
- ATEN $3.77
- FDMT N/A
- Revenue Next Year
- ATEN $8.04
- FDMT $85.25
- P/E Ratio
- ATEN $25.91
- FDMT N/A
- Revenue Growth
- ATEN N/A
- FDMT 784.81
- 52 Week Low
- ATEN $10.55
- FDMT $8.38
- 52 Week High
- ATEN $16.46
- FDMT $36.25
- Technical
- Relative Strength Index (RSI)
- ATEN 63.59
- FDMT 22.67
- Support Level
- ATEN $14.56
- FDMT $8.53
- Resistance Level
- ATEN $14.97
- FDMT $9.29
- Average True Range (ATR)
- ATEN 0.27
- FDMT 0.48
- MACD
- ATEN 0.02
- FDMT 0.02
- Stochastic Oscillator
- ATEN 76.04
- FDMT 2.55
About ATEN A10 Networks Inc.
A10 Networks Inc is a provider of secure application solutions and services that enables a new generation of intelligently connected companies, the ability to continuously improve cyber protection and digital responsiveness across dynamic Information Technology and network infrastructures. Its portfolio consists of six secure application solutions; Thunder Application Delivery Controller, Lightning Application Delivery Controller, Thunder Carrier Grade Networking, Thunder Threat Protection System, Thunder SSL Insight and Thunder Convergent Firewall, and two intelligent management and automation tools; Harmony Controller and aGalaxy TPS. Key revenue is generated from the Americas, with the rest coming from Europe, the Middle East and Africa, plus the Asia Pacific region.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.